Related references
Note: Only part of the references are listed.Formulation and Optimization of Doxorubicin and Biochanin A Combinational Liposomes for Reversal of Chemoresistance
Tapan K. Dash et al.
AAPS PHARMSCITECH (2017)
Curcumin mediates oxaliplatinacquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway
Vicenc Ruiz de Porras et al.
SCIENTIFIC REPORTS (2016)
On-demand combinational delivery of curcumin and doxorubicin via a pH-labile micellar nanocarrier
Haoyu Li et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneity
Bartlomiej Waclaw et al.
NATURE (2015)
Simultaneous delivery of doxorubicin and curcumin encapsulated in liposomes of pegylated RGDK-lipopeptide to tumor vasculature
Sugata Barui et al.
BIOMATERIALS (2014)
Curcumin-cyclodextrin encapsulated chitosan nanoconjugates with enhanced solubility and cell cytotoxicity
Amirali Popat et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2014)
Reaction between lawsone and aminophenol derivatives: Synthesis, characterization, molecular structures and antiproliferative activity
Laxmi Kathawate et al.
JOURNAL OF MOLECULAR STRUCTURE (2014)
Curcumin-Hydroxypropyl-β-Cyclodextrin Inclusion Complex Preparation Methods: Effect of Common Solvent Evaporation, Freeze Drying, and pH Shift on Solubility and Stability of Curcumin
Chutima Jantarat et al.
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH (2014)
Highly Stabilized Curcumin Nanoparticles Tested in an In Vitro Blood-Brain Barrier Model and in Alzheimer's Disease Tg2576 Mice
Kwok Kin Cheng et al.
AAPS JOURNAL (2013)
Effect of curcumin on human colon cancer multidrug resistance in vitro and in vivo
Wei-Dong Lu et al.
CLINICS (2013)
Nanoformulations for Delivery of Biomolecules: Focus on Liposomal Variants for siRNA Delivery
Tapan K. Dash et al.
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS (2013)
Tumour heterogeneity and cancer cell plasticity
Corbin E. Meacham et al.
NATURE (2013)
Overview of P-glycoprotein inhibitors: a rational outlook
Kale Mohana Raghava Srivalli et al.
BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
The tumor microenvironment is a dominant force in multidrug resistance
Ana Luisa Correia et al.
DRUG RESISTANCE UPDATES (2012)
Poly-ε-caprolactone based formulations for drug delivery and tissue engineering: A review
Tapan K. Dash et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Doxil® - The first FDA-approved nano-drug: Lessons learned
Yechezkel (Chezy) Barenholz
JOURNAL OF CONTROLLED RELEASE (2012)
Encapsulation and isomerization of curcumin with cyclodextrins characterized by electronic and vibrational spectroscopy
E. Lopez-Tobar et al.
VIBRATIONAL SPECTROSCOPY (2012)
Discovering Natural Product Modulators to Overcome Multidrug Resistance in Cancer Chemotherapy
Chung-Pu Wu et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Curcumin Nanoparticles: Preparation, Characterization, and Antimicrobial Study
Bhawana et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2011)
SPECIFIC FEATURES OF DRUG ENCAPSULATION IN LIPOSOMES (A REVIEW)
E. V. Tazina et al.
PHARMACEUTICAL CHEMISTRY JOURNAL (2011)
The use of some nanoemulsions based on aqueous propolis and lycopene extract in the skin's protective mechanisms against UVA radiation
Monica V. Butnariu et al.
JOURNAL OF NANOBIOTECHNOLOGY (2011)
被撤回的出版物: Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake (Retracted article. See vol. 102, pg. 142, 2016)
Vivek R. Yadav et al.
BIOCHEMICAL PHARMACOLOGY (2010)
β-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells
Murali Mohan Yallapu et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2010)
Studies of curcumin and curcuminoids. XXXVI. The stoichiometry and complexation constants of cyclodextrin complexes as determined by the phase-solubility method and UV-Vis titration
Ravinder Singh et al.
JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY (2010)
Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines
Stella Chai et al.
Chinese Medicine (2010)
Nanoparticle-assisted combination therapies for effective cancer treatment
Che-Ming Jack Hu et al.
THERAPEUTIC DELIVERY (2010)
Nanocarriers' entry into the cell: relevance to drug delivery
Herve Hillaireau et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Therapeutic Nanoparticles to Combat Cancer Drug Resistance
Che-Ming Jack Hu et al.
CURRENT DRUG METABOLISM (2009)
Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation
Tripta Bansal et al.
DRUG DISCOVERY TODAY (2009)
Emerging Significance of Flavonoids as P-Glycoprotein Inhibitors in Cancer Chemotherapy
Tripta Bansal et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2009)
Multi-functional nanocarriers to overcome tumor drug resistance
Lara S. Jabr-Milane et al.
CANCER TREATMENT REVIEWS (2008)
Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-IR
Bhaumik B. Patel et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Natural and synthetic polymers as inhibitors of drug efflux pumps
Martin Werle
PHARMACEUTICAL RESEARCH (2008)
Comparison of oxaliplatin- and curcumin-mediated antiproliferative effects in colorectal cell lines
Lynne M. Howells et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Targeting multidrug resistance in cancer
G Szakács et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Inhibition of multidrug resistance of cancer cells by natural diterpenes, triterpenes and carotenoids
J Molnar et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal
Cheol-Hee Choi
CANCER CELL INTERNATIONAL (2005)
Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport
SZ Zhang et al.
MOLECULAR PHARMACOLOGY (2004)
P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement
MVS Varma et al.
PHARMACOLOGICAL RESEARCH (2003)
Liposome-based approaches to overcome anticancer drug resistance
C Mamot et al.
DRUG RESISTANCE UPDATES (2003)
Pharmacokinetics of pegylated liposomal doxorubicin - Review of animal and human studies
A Gabizon et al.
CLINICAL PHARMACOKINETICS (2003)
Share Paper
